Invention Application
![SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES](/docs/US/2022-03-17/US20220081438A1/abs.jpg.600x600.jpg)
- Patent Title: SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES
-
Application No.: US17416117Application Date: 2019-12-13
-
Publication No.: US20220081438A1Publication Date: 2022-03-17
- Inventor: James F. Blake , David A. MORENO , Li REN , Tony P. TANG , Shane M. WALLS
- Applicant: ARRAY BIOPHARMA INC.
- Applicant Address: US CO Boulder
- Assignee: ARRAY BIOPHARMA INC.
- Current Assignee: ARRAY BIOPHARMA INC.
- Current Assignee Address: US CO Boulder
- International Application: PCT/US2019/066278 WO 20191213
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
![SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES](/abs-image/US/2022/03/17/US20220081438A1/abs.jpg.150x150.jpg)
Abstract:
Provided herein are compounds of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which Ring A, Ring B, Ring C, R1, R2, L, Y, and W have the meanings given in the specification, which are inhibitors of FGFR1, FGFR2, FGFR3 and/or FGFR4 and are useful in the treatment and prevention of diseases which can be treated with an FGFR inhibitor, including diseases or disorders mediated by FGFR1, FGFR2, FGFR3 and/or FGFR4.
Public/Granted literature
- US12180207B2 Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases Public/Granted day:2024-12-31
Information query
